Thromboembolism as a factor associated with the use of hormonal contraceptives.

• Autor(a) principal: Venâncio , Diego Sigesfredo Santos
• Data de Publicação: 2023
• Outros Autores: Alves , Tatiane Vilela de Oliveira, Soares, Joyce Rafaela, Soares, Rebeca Chaves, Carvalho, Carina Pereira de, Formiga, Cristina Maria Oliveira Martins, Valente , Camila de Souza, Souza , Andressa Regina Luz de, Silva , Carolina Souza da, Mendes, Regina Vitória Costa, Brito, Victoria Santos de Araújo, Jarussi , Mariana Benicio, Santana, Arianny Luiza Barros de
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/551
• topic: Anticoncepcional Hormonal; Fatores de Risco; Tromboembolismo.

INTRODUCTION: Hormonal contraceptive methods are constantly used nowadays, with a view to contraception. In developed countries such as the United States, there is a range of around 18% of use of different methods among women. In developing countries like Brazil, this percentage reaches up to 75%. OBJECTIVE: To present, according to scientific literature, the main factors associated with the use of contraceptives in the development of thromboembolism. METHODOLOGY: This is a qualitative study, it refers to an integrative review of the literature, presenting a synthesis of the studies analyzed in full, organizing them for the elaboration of results regarding the established theme, being carried out in the month of September 2023. RESULTS: The development  of  Thromboembolism  caused  by  the  various oral  contraceptive methods  is  evidenced  through  studies that  demonstrate  the  serious  risks  to  female  health, requiring  greater caution  in the use  of  hormonal  and emergency  pills. FINAL CONSIDERATIONS: Therefore, it is noted that the use of hormonal contraceptives brings benefits such as preventing conception, however it can be a major factor in the development of thromboembolism.